disulfiram has been researched along with Myelodysplastic Syndromes in 1 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, new therapeutic approaches are urgently needed for MDS patients harboring adverse prognostic factors." | 5.62 | Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. ( Bi, S; Chen, K; Deng, M; Feng, L; Guo, C; He, J; Jiang, Y; Li, Z; Pu, X; Shi, P; Song, H; Xu, B; Zha, J; Zhao, H, 2021) |
| " Therefore, new therapeutic approaches are urgently needed for MDS patients harboring adverse prognostic factors." | 1.62 | Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. ( Bi, S; Chen, K; Deng, M; Feng, L; Guo, C; He, J; Jiang, Y; Li, Z; Pu, X; Shi, P; Song, H; Xu, B; Zha, J; Zhao, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zha, J | 1 |
| Bi, S | 1 |
| Deng, M | 1 |
| Chen, K | 1 |
| Shi, P | 1 |
| Feng, L | 1 |
| He, J | 1 |
| Pu, X | 1 |
| Guo, C | 1 |
| Zhao, H | 1 |
| Li, Z | 1 |
| Jiang, Y | 1 |
| Song, H | 1 |
| Xu, B | 1 |
1 other study available for disulfiram and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferati | 2021 |